Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Almotriptan Malate.

Client Email

Product

Almotriptan Malate
Almotriptan
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Almotriptan Malate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 1 CEP/COS, 5 EU WC, 3 NDC API, 9 Listed Suppliers, $ API Reference Price

15 API Suppliers
6 USDMF
1 CEP/COS
5 EU WC
3 NDC API
9 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 6 Canada

25 FDF Dossiers
8 FDA Orange Book
11 Europe
6 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 2 DKSH, 2 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 30 Direct Compression, 29 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 19 Granulation, 19 Thickeners and Stabilizers, 15 Solubilizers, 14 Co-Processed Excipients, 14 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Film Formers & Plasticizers, 10 Lubricants & Glidants, 10 Topical, 9 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Rheology Modifiers, 2 Emulsifying Agents

48 Fillers, Diluents & Binders
45 Coating Systems & Additives
30 Direct Compression
29 Disintegrants & Superdisintegrants
27 Controlled & Modified Release
19 Granulation
19 Thickeners and Stabilizers
15 Solubilizers
14 Co-Processed Excipients
14 Chewable & Orodispersible Aids
12 Taste Masking
11 Film Formers & Plasticizers
10 Lubricants & Glidants
10 Topical
9 Parenteral
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
3 Rheology Modifiers
2 Emulsifying Agents

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

1 US Medicaid Prescriptions
4 Finished Drug Prices

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

2 USP
1 Others

$ API Ref.Price (USD/KG) : 9,514 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2McNeil Consumer Healthcare

filter Patent Reset all filters

2 All

01 22120028

filter Product Reset all filters

2 All

01 2Almotriptan Malate

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 22013-07-19

Product Main Page

01

McNeil Consumer Healthcare

Almotriptan Malate

Formnext Forum

Not Confirmed

McNeil Consumer Healthcare

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Almotriptan Malate

Brand Name : AXERT

Patent Number : 2120028

Filing Date : 1993-07-19

Strength per Unit : 12.5mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

02

McNeil Consumer Healthcare

Almotriptan Malate

Formnext Forum

Not Confirmed

McNeil Consumer Healthcare

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Almotriptan Malate

Brand Name : AXERT

Patent Number : 2120028

Filing Date : 1993-07-19

Strength per Unit : 6.25mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2013-07-19

Date Granted : 1999-03-23

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?